Kingasa Pilot Study

NACompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
HIVLinkage to CarePMTCTPrEPART Adherence
Interventions
DIAGNOSTIC_TEST

POC viral load testing

POC viral load testing- women randomized to have POC VL at enrollment, delivery and 6 months post-partum, will have a finger prick to obtain whole blood for the Cepheid Xpert HIV-1 RNA cartridge on the Xpert IV machine with results in 90 minutes. Women who are randomized to POC VL who have VL \>200 c/ml will receive additional adherence counseling, following the STREAM protocol, \[26\] to address the challenges that they are having with ART use. At the delivery visit, infants of women in the POC VL arm will also have viral load testing done.

OTHER

Wellness visit services for male partners

Wellness visits for men- additional prevention services for men randomized to the intervention arm, including dual syphilis and HIV testing, blood pressure, visual acuity screening, and COVID-19 screening as part of wellness

Trial Locations (1)

Unknown

Infectious Disease Institute, Kampala

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Harvard University

OTHER

lead

University of Washington

OTHER

NCT05092997 - Kingasa Pilot Study | Biotech Hunter | Biotech Hunter